Laminin α2 muscular dystrophy
- 1 July 1998
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 51 (1) , 101-110
- https://doi.org/10.1212/wnl.51.1.101
Abstract
Objective: To determine the number of primary laminin α2 gene mutations and to conduct genotype/phenotype correlation in a cohort of lamininα2-deficient congenital muscular dystrophy patients. Background: Congenital muscular dystrophies (CMD) are a heterogenous group of muscle disorders characterized by early onset muscular dystrophy and a variable involvement of the CNS. Laminin α2 deficiency has been reported in about 40 to 50% of cases of the occidental, classic type of CMD.1,2 Laminin α2 is a muscle specific isoform of laminin localized to the basal lamina of muscle fibers, where it is thought to interact with myofiber membrane receptor, such as integrins, and possibly dystrophin-associated glycoproteins.3,4 Methods: Seventy-five CMD patients were tested for laminin α2 expression by immunofluorescence and immunoblot. The entire 10 kb laminin α2 coding sequence of 22 completely laminin α2-deficient patients was screened for causative mutations by reverse transcription (RT)-PCR/single strand conformational polymorphisms (SSCP) analysis and protein truncation test(PTT) analysis followed by automatic sequencing of patient cDNA. Clinical data from the laminin α2-deficient patients were collected. Results: Thirty laminin α2-negative patients were identified (40% of CMD patients tested) and 22 of them were screened for laminin α2 mutations. Clinical features of laminin α2-deficient patients were similar, with severe floppiness at birth, delay in achievement of motor milestones, and MRI findings of white matter changes with normal intelligence. Loss-of-function mutations were identified in 95% (21/22) of the patients studied. SSCP analysis detected laminin α2 gene mutations in about 50% of the mutant chromosomes; PTT successfully identified 75% of the mutations. A two base pair deletion mutation at position 2,096-2,097 bp was present in 23% of the patients analyzed. Conclusions: Our data suggest that the large majority of laminin α2-deficient patients show laminin α2 gene mutations.Keywords
This publication has 9 references indexed in Scilit:
- EditorialPathology, 1996
- Deficiency of Merosin (Laminin M or α2) in Congenital Muscular Dystrophy Associated with Cerebral White Matter AlterationsNeuropediatrics, 1995
- Merosin‐negative congenital muscular dystrophy associated with extensive brain abnormalitiesNeurology, 1995
- Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophyNeurology, 1995
- Prenatal diagnosis in congenital muscular dystrophyThe Lancet, 1995
- Prenatal Detection of Merosin Expression in Human PlacentaNeuropediatrics, 1994
- Merosin, a tissue-specific basement membrane protein, is a laminin-like protein.Proceedings of the National Academy of Sciences, 1990
- Association of dystrophin and an integral membrane glycoproteinNature, 1989
- Muscle, Eye and Brain Disease: A New SyndromeNeuropediatrics, 1977